Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Daiichi Sankyo to Buy Ambit to Boost Cancer Drug Pipeline
Daiichi Sankyo to Buy Ambit to Boost Cancer Drug Pipeline
Daiichi Sankyo to Buy Ambit to Boost Cancer Drug Pipeline
Submitted by
admin
on September 29, 2014 - 7:55am
Source:
Bloomberg
News Tags:
Daiichi Sankyo
Ambit Biosciences
M&A
Headline:
Daiichi Sankyo to Buy Ambit to Boost Cancer Drug Pipeline
Do Not Allow Advertisers to Use My Personal information
